Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1546]

WCLC 2024: Ivonescimab outperforms pembrolizumab in phase 3 study for first-line treatment of PD-L1-positive advanced NSCLC in HARMONi-2 study

WCLC 2024: Ivonescimab outperforms pembrolizumab in phase 3 study for first-line treatment of PD-L1-positive...

Pancreatic cancers change identity as they transform into aggressive types ― an organoid study

Pancreatic cancers change identity as they transform into aggressive types ― an organoid study

Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging

Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging

Researchers identify key markers in pancreatic cancer progression using a new analysis pipeline

Researchers identify key markers in pancreatic cancer progression using a new analysis pipeline

Scientists discover how the body's killer cells attack cancer

Scientists discover how the body's killer cells attack cancer

Old chemotherapy drug, new pancreatic cancer therapy?

Old chemotherapy drug, new pancreatic cancer therapy?

Novel DNA-targeting therapeutic screening technique developed

Novel DNA-targeting therapeutic screening technique developed

Faster detection of pancreatic cancer

Faster detection of pancreatic cancer

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

More from ecancer